Results 11 to 20 of about 38,393 (221)

Thiazolidinediones [PDF]

open access: yesTreatments in Endocrinology, 2006
Our knowledge and understanding of the role played by peroxisome proliferator-activated gamma receptors in physiology and pathophysiology has expanded dramatically over the past 5 years. Originally described as having important functions in adipogenesis and glucose homeostasis, their pharmacologic agonists, the thiazolidinediones, were introduced as ...
Kathryn, Reynolds, Ronald B, Goldberg
  +7 more sources

Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia

open access: yesPharmaceutics, 2022
Thiazolidinediones (TZDs) are potent PPARγ agonists that have been shown to attenuate alveolar simplification after prolonged hyperoxia in term rodent models of bronchopulmonary dysplasia.
Giorgio Aquila   +21 more
doaj   +1 more source

Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.

open access: yesPLoS ONE, 2014
Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the ...
Dongfeng Zhao   +6 more
doaj   +1 more source

The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes

open access: yesBiomolecules, 2022
The number of patients with type 2 diabetes mellitus (T2DM), which is mainly characterized by insulin resistance and insulin secretion deficiency, has been soaring in recent years.
Xiaohui Ji   +6 more
doaj   +1 more source

Association between colorectal cancer and thiazolidinediones administration in a case-control study

open access: yesBioMedicine, 2019
Objectives: This study was designed to assess whether there was an association between colorectal cancer and thiazolidinediones use. Methods: A population-based case-control study was performed using the database of the Taiwan National Health ...
Liao Kuan-Fu, Lin Cheng-Li, Lai Shih-Wei
doaj   +1 more source

Short-term therapy with rosiglitatzone, a PPAR-¿ agonist improves metabolic profile and vascular function in non-obese lean wistar rats [PDF]

open access: yes, 2012
A number of preclinical and clinical studies have reported blood-pressure-lowering benefits of thiazolidinediones in diabetic subjects and animal models of diabetes.
Abubakari, Abdul-Razak   +3 more
core   +1 more source

Self-controlled case series with multiple event types [PDF]

open access: yes, 2017
Self-controlled case series methods for events that may be classified as one of several types are described. When the event is non-recurrent, the different types correspond to competing risks.
Douglas, Ian J.   +4 more
core   +1 more source

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke [PDF]

open access: yesJournal of Stroke, 2019
Patients with hyperglycemia are at a high risk of cardio- and cerebrovascular diseases. Diabetes patients also have poor outcomes after cerebrovascular disease development.
Chang Ho Ahn, Soo Lim
doaj   +1 more source

Effects of vildagliptin on ventricular function in patients with type 2 diabetes mellitus and heart failure: a randomized placebo-controlled trial [PDF]

open access: yes, 2017
Objectives: This study sought to examine the safety of the dipeptidyl peptidase-4 inhibitor, vildagliptin, in patients with heart failure and reduced ejection fraction.
Bolli, Geremia B.   +7 more
core   +2 more sources

Adsorption Mechanism of Eco-Friendly Corrosion Inhibitors for Exceptional Corrosion Protection of Carbon Steel: Electrochemical and First-Principles DFT Evaluations

open access: yesMetals, 2022
In the present work, we represent two thiazolidinediones, namely (Z)-5-(4-methoxybenzylidene) thiazolidine-2,4-dione (MeOTZD) and (Z)-5-(4-methylbenzylidene) thiazolidine-2,4-dione (MeTZD), as corrosion inhibitors for carbon steel (CS) in 1.0 M HCl ...
Abdelkarim Chaouiki   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy